United States News Todas as matérias

A months-long dispute between the Trump administration and AI firm Anthropic is showing signs of cooling as the company navigates the final stages of its preparation for a highly anticipated initial public offering.

Global oil prices showed stability on Friday as market participants parsed conflicting signals from the Middle East.

Guidewire Software (NYSE:GWRE) reported strong financial results for its fiscal third quarter ended April 30, 2026, delivering a 27% year-over-year revenue increase to $372.5 million.

Planet Labs (NYSE:PL), a leading provider of daily geospatial data and insights, reported record revenue of $94.2 million for its fiscal first quarter ended April 30, 2026.

DocuSign (NASDAQ:DOCU) reported financial results for its first quarter of fiscal year 2027 ended April 30, 2026, delivering performance that surpassed market expectations.

The U.S. Supreme Court delivered a significant victory to the Federal Communications Commission (FCC) on Thursday, June 4, 2026, ruling that the agency's internal system for imposing financial penalties—known as "forfeiture orders"—does not violate the Seventh Amendment right to a jury trial.

Pinterest (NYSE:PINS) today announced a major expansion of its long-standing collaboration with Amazon Web Services (AWS), entering into a planned $4 billion commitment for cloud services through 2031.

The Board of Directors of Nordson (NASDAQ:NDSN) has declared a cash dividend of $0.82 per common share for the third quarter of fiscal year 2026.

MIRA Pharmaceuticals (NASDAQ:MIRA) announced that it has executed an Amended and Restated Exclusive License Agreement with MIRALOGX.

Xenetic Biosciences (NASDAQ:XBIO) announced today that its collaboration partner, PeriNess, has received formal approval from the Israeli Ministry of Health and the relevant Institutional Review Board to initiate an exploratory clinical study.

Teva Pharmaceutical (NYSE:TEVA) announced the launch of AHZANTIVE (aflibercept), a biosimilar to Eylea, across several major European markets, including France, Germany, Spain, and the Netherlands.

GameSquare Holdings (NASDAQ:GAME) issued a shareholder update today projecting significant growth for the second quarter of 2026.

The Toro Company (NYSE:TTC) reported strong financial results for its fiscal second quarter ended May 1, 2026, as the company benefited from sustained demand across its professional and residential segments during the critical spring selling season.

IQSTEL (NASDAQ:IQST) announced today that it has signed a binding Memorandum of Understanding (MOU) to acquire a 51% controlling interest in Ultranet Telecom Group.

Brown-Forman (NYSE:BFA) today reported financial results for its fourth quarter and full fiscal year ended April 30, 2026.

Mobix Labs (NASDAQ:MOBX) announced today that it has entered into a binding Letter of Intent (LOI) to acquire Vision Aerial, a Montana-based manufacturer of high-end unmanned aerial systems (UAS).

Biogen (NASDAQ:BIIB) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to its investigational antisense oligonucleotide, salanersen, for the treatment of spinal muscular atrophy (SMA).

Fractyl Health (NASDAQ:GUTS) today announced positive one-year, open-label results from its REVEAL-1 study, which evaluated the Revita® duodenal mucosal resurfacing procedure in patients who had discontinued the use of GLP-1 receptor agonist medications.

Gogo (NASDAQ:GOGO) announced today that its military and government subsidiary, SD Government, has secured a multi-year blanket purchase agreement with the National Oceanic and Atmospheric Administration (NOAA).

LeonaBio (NASDAQ:LONA) announced today that Chief Medical Officer Javier San Martin, MD, presented the company’s clinical strategy for its lead ALS candidate, brelgometon (ATH-1105), at the 5th Annual ALS Drug Development Summit in Boston.

Orion Energy Systems (NASDAQ:OESX) reported financial results for its fiscal year 2026 today, detailing a period of ongoing investment and operational transition.

AN2 Therapeutics (NASDAQ:ANTX) announced positive data today from two separate studies evaluating its investigational oral CPSF3 inhibitor, AN2-502998, for the treatment of chronic Chagas disease—a parasitic condition caused by Trypanosoma cruzi that affects millions globally.

Click Holdings (NASDAQ:CLIK), a Hong Kong-based provider of human resources and senior care solutions, reported strong operational growth for the third quarter of its 2025/26 financial year, covering the period from January to March 2026.

TKO Group Holdings (NYSE:TKO) announced today that its board of directors has declared a quarterly cash dividend.